SCHEMBL9954809

SCHEMBL9954809

CCCCCCCCCCCCCCCCC(O)(C(=O)O)C(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPD1 P10809 1/20 0.49
BLM P54132 1/20 0.49
HSPE1 P61604 1/20 0.49
MEN1 O00255 1/20 0.44
HPGD P15428 1/20 0.44
RECQL P46063 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.44
FDPS P14324 8/20 0.42
GGPS1 O95749 5/20 0.42
CES2 O00748 1/20 0.41
GPR84 Q9NQS5 2/20 0.40
PPARG P37231 2/20 0.40
PPARD Q03181 2/20 0.40
PPARA Q07869 2/20 0.40
ALDH1A1 P00352 1/20 0.40
TSHR P16473 1/20 0.40
SLC22A6 Q4U2R8 1/20 0.40
SLC22A8 Q8TCC7 1/20 0.40
TLR2 O60603 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28928385 1.00 HSPD1 (0.49) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL11824865 0.92 HSPD1 (0.43) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL3929724 0.83 HSPD1 (0.49) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL14920851 0.83 HSPD1 (0.38) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL1735473 0.81 HSPD1 (0.54) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL8990173 0.81 HSPD1 (0.50) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL30236384 0.81 HSPD1 (0.50) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL31266575 0.81 HSPD1 (0.46) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL7773503 0.81 HSPD1 (0.50) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL1354984 0.81 HSPD1 (0.50) HSPD1BLMHSPE1MEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2654665-A2 METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH (DE) 2013-10-30 EP disclosed
WO-2012083906-A2 METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY MIKA PHARMA GESELLSCHAFT FÜR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) 2012-06-28 WO disclosed